Skip to main content
profileAnalyst coverage5 yr. financialspremium researchdividendsadv. chartsearningsoptions

Synthorx, Inc. News

France's Sanofi to Buy Cancer-Drug Specialist Synthorx for $68-Share, or $2.5 Billion

The deal price is nearly triple Synthorx's Friday closing price above $25. One of Sanofi's goals is to build its oncology franchise, the CEO said in a statement.

Merck & Co. Acquires Cancer Drug Specialist ArQule For $2.7 Billion

ArQule shares surge after the cancer drug specialists agreed to a $2.7 billion takeover bid from Merck & Co.

Jim Cramer Reacts to Thor Industries Earnings

Jim Cramer said millennials played a big part in Thor Industries' colossal earnings beat.

Thor Industries Drops Double Digits on Mixed Earnings

Thor Industries beat FactSet's expectations but missed Zacks bottom-line estimates.

Oil, Yellen and world gdp growth: How to trade the week ahead

Conditions seem ripe for continued upward momentum in stocks, as long as the Federal Reserve or unexpected shocks don't get in the way.

Breaking News

Cord Cutting Keeps Growing. Here's What It Means for You

Fubo, Hulu Live, and Sling were supposed to be alternatives to traditional cable.

How to Purge Gun Stocks From Your 401(k)

After mass shootings, a lot of investors are saying enough if enough.

Costco Beats Q3 Sales Forecast, Membership Revenues Near $1 Billion

Costco took in $984 million in new membership fee in its fiscal third quarter, helping the bulk retailer top Street forecasts for topline revenues.

Broadcom Agrees to Buy VMware in $61 Billion Cash-and-Stock Cloud Software Deal

"Combining our assets and talented team with Broadcom's existing enterprise software portfolio creates a remarkable enterprise software player," said VMware CEO Raghu Raghuram.